Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most

Background The advent of biologics and janus kinase inhibitors has revolutionized treatment of atopic dermatitis (AD).Objective To investigate preferences of patients with AD for attributes of currently approved systemic treatments and assess influencing factors.Methods An online discrete choice exp...

Full description

Saved in:
Bibliographic Details
Main Authors: Marthe-Lisa Schaarschmidt, Daniel Kromer, Phoebe Wellmann, Wiebke K. Peitsch, Christian Kromer
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2308682
Tags: Add Tag
No Tags, Be the first to tag this record!